Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Terminated 1Active not recruiting 1

Sponsor Class

NETWORK 10NIH 8OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2Sarcoma 1

Conditions

Breast Neoplasms 9470Neoplasms 6584Prostatic Neoplasms 4397Colorectal Neoplasms 3975Lung Neoplasms 3638Carcinoma, Non-Small-Cell Lung 3579Pancreatic Neoplasms 2476Carcinoma, Hepatocellular 2409Leukemia, Myeloid, Acute 2264Multiple Myeloma 2118Stomach Neoplasms 2107Neoplasm Metastasis 1911Head and Neck Neoplasms 1867Ovarian Neoplasms 1771Precursor Cell Lymphoblastic Leukemia-Lymphoma 1732Lymphoma 1729Brain Neoplasms 1697Rectal Neoplasms 1675Melanoma 1654Colonic Neoplasms 1629Leukemia 1499Uterine Cervical Neoplasms 1497Recurrence 1483Esophageal Neoplasms 1310Glioblastoma 1305Lymphoma, Non-Hodgkin 1204Leukemia, Lymphocytic, Chronic, B-Cell 1120Squamous Cell Carcinoma of Head and Neck 1109Urinary Bladder Neoplasms 1078Lymphoma, Follicular 1067

Interventions

linrodostat 1Taxes 1Paclitaxel 1Nivolumab 1Carboplatin 1Brachytherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Endometrial Adenocarcinoma × Clear all
NCT04106414 2025-10-14

Study of BMS-986205 and Nivolumab in Endometrial Cancer or Endometrial Carcinosarcoma That Has Not Responded to Treatment

Memorial Sloan Kettering Cancer Center

Phase 2 Active not recruiting
24 enrolled
GynecologicSarcoma

Endometrial Adenocarcinoma

NCT01041027 2023-10-26

Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Endometrial Cancer

Albert Einstein College of Medicine

Phase 2 Terminated
31 enrolled 8 charts
Gynecologic

Endometrial Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡